Stock Market News
Results Round-up
18-02-2013 16:06
| Add To Google +1 | Tweet |
Shares in AIM-listed Sareum Holdings, the specialist cancer drug discovery business, fell sharply on Monday morning after the company unveiled its half yearly results alongside a research update.
Cash at bank as of December 31st fell 28% to £380,000 and the company reported a loss on ordinary activities after taxation of £269,000. This was less than the reduction reported a year earlier, worth £327,000.
In a separate research update, progress reports were given for a number of the company's programmes showing the level of development that had been measured as well as existing and expected funding options.
Describing the programme known as "VEGFR-3 (FLT4)", the company said: "We have prioritised our research spend on other programmes whilst we investigate grant funding opportunities alongside a partner with the necessary biology expertise to assist us in the progression of this programme."
More detailed updates were given on the company's other programmes. Safety pharmacology studies performed to date on the "Chk1" programme's pre-clinical development candidate were described as "favourable". Oral bio-availability was demonstrated in three species, strengthening its expectation that the compound would be able to be administered via the oral route in future clinical studies.
Head-to-head studies were continuing between two advanced lead molecules as part of the "Aurora+FLT3" with the aim of selecting a pre-clinical development candidate by the middle of the year.
Self-storage firm Lok'n'Store said trading for the first half of the financial year has been in line with expectations.
The group said strong occupancy growth supported by VAT changes helped trading for the year to January 31st 2013, with revenue for the period up 2.2% on last year.
"Our lead indicators are also good, with occupancy at January 31st up 6.1% year-on-year," it said.
This compares to last year when occupancy was down 0.3% in its traditionally weaker period.
Lok'n Store also noted that since the harmonisation of VAT across the UK self-storage industry on October 1st 2012, the number of move-ins soared 12.4% from the same period a year earlier.
CEO Andrew Jacobs explained: "The harmonisation of VAT across the UK self-storage sector has benefited Lok'nStore with our major competitors having to register for VAT, while our own business was already VAT compliant."
"Activity levels across the portfolio have been robust, reflected by our strong occupancy growth of 6.1% year-on-year. We expect this to continue into the second half and into the next financial year."
Jacobs also offered an upbeat outlook, citing robust revenue and occupancy growth from existing stores, combined with the opening of its new Maidenhead store later this year and the Aldershot store in 2014.
"This will provide continued impetus for our sales growth," he added.
Cash at bank as of December 31st fell 28% to £380,000 and the company reported a loss on ordinary activities after taxation of £269,000. This was less than the reduction reported a year earlier, worth £327,000.
In a separate research update, progress reports were given for a number of the company's programmes showing the level of development that had been measured as well as existing and expected funding options.
Describing the programme known as "VEGFR-3 (FLT4)", the company said: "We have prioritised our research spend on other programmes whilst we investigate grant funding opportunities alongside a partner with the necessary biology expertise to assist us in the progression of this programme."
More detailed updates were given on the company's other programmes. Safety pharmacology studies performed to date on the "Chk1" programme's pre-clinical development candidate were described as "favourable". Oral bio-availability was demonstrated in three species, strengthening its expectation that the compound would be able to be administered via the oral route in future clinical studies.
Head-to-head studies were continuing between two advanced lead molecules as part of the "Aurora+FLT3" with the aim of selecting a pre-clinical development candidate by the middle of the year.
Self-storage firm Lok'n'Store said trading for the first half of the financial year has been in line with expectations.
The group said strong occupancy growth supported by VAT changes helped trading for the year to January 31st 2013, with revenue for the period up 2.2% on last year.
"Our lead indicators are also good, with occupancy at January 31st up 6.1% year-on-year," it said.
This compares to last year when occupancy was down 0.3% in its traditionally weaker period.
Lok'n Store also noted that since the harmonisation of VAT across the UK self-storage industry on October 1st 2012, the number of move-ins soared 12.4% from the same period a year earlier.
CEO Andrew Jacobs explained: "The harmonisation of VAT across the UK self-storage sector has benefited Lok'nStore with our major competitors having to register for VAT, while our own business was already VAT compliant."
"Activity levels across the portfolio have been robust, reflected by our strong occupancy growth of 6.1% year-on-year. We expect this to continue into the second half and into the next financial year."
Jacobs also offered an upbeat outlook, citing robust revenue and occupancy growth from existing stores, combined with the opening of its new Maidenhead store later this year and the Aldershot store in 2014.
"This will provide continued impetus for our sales growth," he added.
| Related share prices |
|---|
Stock News is provided by Digital Look Corporate Solutions from Sharecast news. Please read the terms and conditions of useage of this data. Republication or redistribution of content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd.
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- UK 100 Shares
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways share price
- Centrica share price
- Tesco share price
- National Grid share price
- RBS share price
- GSK share price
- Marks and Spencer
- Rolls Royce
- Banco Santander price
- Direct Line
- Rio Tinto share price
- Amec Share price
- Corac share price
- Lookers
- Telecom plus
- Kier share price
- Punch taverns
- Blinkx share price
- Tan share price
- Yell share price
- Rsa share price
- Pendragon share price
- Logica share price
- Bat share price
- Sky share price
- Kingfisher share price
- Dragon Oil share price
- Desire Petroleum share price
- RRL share price
- BPC share price
- VOG share price
- SAR share price


Prices

